Tonix Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. 

CEO
Seth Lederman
CEOSeth Lederman
Employees
142
Employees142
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2007
Founded2007
Employees
142
Employees142

TNXP Key Statistics

Market cap
173.06M
Market cap173.06M
Price-Earnings ratio
-0.90
Price-Earnings ratio-0.90
Dividend yield
Dividend yield
Average volume
558.12K
Average volume558.12K
High today
$13.75
High today$13.75
Low today
$12.70
Low today$12.70
Open price
$13.57
Open price$13.57
Volume
769.62K
Volume769.62K
52 Week high
$69.97
52 Week high$69.97
52 Week low
$12.70
52 Week low$12.70

Stock Snapshot

The current Tonix Pharmaceuticals(TNXP) stock price is $13.19, with a market capitalization of 173.06M. The stock trades at a price-to-earnings (P/E) ratio of -0.90.

On 2026-03-30, Tonix Pharmaceuticals(TNXP) stock moved within a range of $12.70 to $13.75. With shares now at $13.19, the stock is trading +3.9% above its intraday low and -4.1% below the session's peak.

Trading activity shows a volume of 769.62K, compared to an average daily volume of 558.12K.

Over the past 52 weeks, Tonix Pharmaceuticals(TNXP) stock has traded between a high of $69.97 and a low of $12.70.

Over the past 52 weeks, Tonix Pharmaceuticals(TNXP) stock has traded between a high of $69.97 and a low of $12.70.

TNXP News

TipRanks 4d
Tonix Pharma Begins Phase 1 Study of TNX-1900

Tonix Pharma ( (TNXP) ) has provided an update. On March 26, 2026, Tonix Pharmaceuticals announced that the first participant was dosed in a Phase 1 investigat...

TipRanks 4d
Tonix Pharmaceuticals doses first patient in TNX-1900 study

Tonix Pharmaceuticals (TNXP) announced that the first participant has been dosed in a Phase 1 investigator-initiated study to evaluate the effect of TNX-1900 on...

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.